![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/047 | |
A61K 31/191 | |||
A61K 31/352 | |||
A61K 45/06 | |||
A61P 17/02 | |||
A61P 17/14 | |||
A61P 17/06 | |||
A61P 17/10 |
(11) | Number of the document | 3355873 |
(13) | Kind of document | T |
(96) | European patent application number | 16777760.6 |
Date of filing the European patent application | 2016-09-29 | |
(97) | Date of publication of the European application | 2018-08-08 |
(45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2016/053027 |
Date | 2016-09-29 |
(87) | Number | WO 2017/055846 |
Date | 2017-04-06 |
(30) | Number | Date | Country code |
201517215 | 2015-09-29 | GB |
(72) |
B R , Tamįs, HU
STOTT, Colin, GB
DI MARZO, Vincenzo, GB
|
(73) |
GW Pharma Limited,
Sovereign House Vision Park Chivers Way Histon, Cambridge, Cambridgeshire CB24 9BZ,
GB
|
(54) | USE OF CANNABINOIDS IN THE TREATMENT OF INFLAMMATORY SKIN DISEASES |
USE OF CANNABINOIDS IN THE TREATMENT OF INFLAMMATORY SKIN DISEASES |